Neuron-Related Blood Inflammatory Markers as an Objective Evaluation Tool for Major Depressive Disorder: An Exploratory Pilot Case-Control Study

Major depressive disorder (MDD) is a common psychiatric disorder. The prevalence of MDD is considered to be 4.7% worldwide, and its burden is extremely large (DALYs and Collaborators, 2017; Ferrari et  al., 2013). However, MDD diagnosis and symptom evaluation have depended on subjective information such as physician's clinical experiences and patient's self-assessments, which can unfortunately lead to misdiagnoses (Mitchell et al., 2009). Such difficulties have caused confusion in clinical pra ctice of MDD (Kato et al., 2016; Kato and Kanba, 2017; Kato et al., 2011b; Kato et al., 2011c).

Source: Journal of Affective Disorders - July 16, 2018 Category: Neurology Authors: Nobuki Kuwano, Takahiro A. Kato, Masato Mitsuhashi, Mina Sato-Kasai, Norihiro Shimokawa, Kohei Hayakawa, Masahiro Ohgidani, Noriaki Sagata, Hiroaki Kubo, Takeshi Sakurai, Shigenobu Kanba Source Type: research